Why Morgans rates these 3 ASX 200 stocks as buys

These stocks have been given the thumbs up by the broker this week.

| More on:
A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Morgans has been busy looking at insurance and diversified financials shares and have picked out three that it rates as "standout picks" this week.

Let's see what the broker is saying about them:

Challenger Ltd (ASX: CGF)

Morgans was impressed with this annuities company's performance in FY 2024. And given its positive outlook and undemanding valuation, it believes now could be a good time to buy the ASX 200 stock. It said:

CGF's FY24 normalised NPAT (A$417m) was in-line with consensus and +14% on the pcp. Overall, we saw this as a positive FY24 result highlighted by a strong improvement in Life business margins/returns, good group cost control and an upward step change in CGF's capital position. We lift our CGF FY25F/FY26F EPS by 4%-6% on higher Life business margin expectations, and a reduction in our cost-to-income ratio forecasts. With CGF having good earnings momentum, and trading on an undemanding 12x FY25F PE multiple, we see further upside.

Morgans has an add rating and $8.66 price target on its shares.

QBE Insurance Group Ltd (ASX: QBE)

The broker was also pleased with this insurance giant's performance during the first half of FY 2024. It was in line with expectations and believes it supports its view that QBE's shares are dirt cheap at current levels. It explains:

QBE's 1H24 result was broadly in-line at both Gross Written Premium (GWP) and NPAT, with the company delivering a solid 16.9% ROE (10.1% in the pcp). Overall we saw this result as largely as expected, with the negative being slightly lowered FY24 top-line guidance, and the positive being an improved overall North America business performance. We lower our QBE FY24F/FY25 EPS by 9%/5% reflecting; restructuring charges, reduced top-line growth expectations, higher tax rate forecasts and a change in QBE's definition of adjusted NPAT. We continue see QBE as too cheap, trading on 10x FY24F PE.

Morgans has an add rating and $18.73 price target the ASX 200 stock.

Suncorp Group Ltd (ASX: SUN)

While this insurance giant's result was short of expectations, it was pleased with its guidance for the year ahead. It said:

SUN's FY24 cash NPAT (A$1,372m) was ~-5% below consensus (A$1,425m), mainly due to a softer General Insurance result than expected. FY25 guidance points to solid earnings momentum continuing into this year, and we see SUN's unveiled FY25-FY27 business strategy as uncomplicated and focused on driving the insurance business harder (which should be well received). We lift our SUN FY25F/FY26F EPS by 5-6% on an increase in insurance margin forecasts and lower "other items" forecasts.

Morgans has an add rating and $18.92 price target on its shares.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Challenger. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A miner stands in front oh an excavator at a mine site
Broker Notes

Broker says buy the dip on ASX 200 uranium share with 69% upside

Shaw and Partners says this ASX uranium stock is trading at an attractive price point right now.

Read more »

A young man punches the air in delight as he reacts to great news on his mobile phone.
Broker Notes

Bell Potter says these ASX stocks are top buys

Let's see why the broker is feeling so bullish on these names.

Read more »

A man holding a cup of coffee puts his thumb up and smiles while at laptop.
Broker Notes

Buy this ASX All Ords stock for huge returns and a great dividend yield

Bell Potter thinks this buy-rated stock could deliver the goods for investors over the next 12 months.

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to snap up these stocks.

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Broker Notes

Top broker says these ASX stocks can rise 35% in a year

Let's see why Bell Potter thinks these shares could rise strongly over the next 12 months.

Read more »

A man has a surprised and relieved expression on his face. as he raises his hands up to his face in response to the high fluctuations in the Galileo share price today
Broker Notes

These ASX shares could rise 20% to 50%

Analysts are tipping these shares to rise strongly over the next 12 months.

Read more »

A female ASX investor looks through a magnifying glass that enlarges her eye and holds her hand to her face with her mouth open as if looking at something of great interest or surprise.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

Doctor doing a telemedicine using laptop at a medical clinic
Healthcare Shares

3 small-cap ASX healthcare shares 'with strong prospects'

Fund manager IML discusses why these 3 ASX healthcare shares are likely to rise in value.

Read more »